Compare ICUI & HSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ICUI | HSAI |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.8B |
| IPO Year | 1995 | 2021 |
| Metric | ICUI | HSAI |
|---|---|---|
| Price | $131.20 | $21.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $178.50 | $31.58 |
| AVG Volume (30 Days) | 229.9K | ★ 2.1M |
| Earning Date | 05-07-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.62 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $2,231,262,000.00 | N/A |
| Revenue This Year | N/A | $46.32 |
| Revenue Next Year | $4.46 | $41.24 |
| P/E Ratio | $4,330.17 | ★ $61.18 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $107.02 | $12.06 |
| 52 Week High | $160.29 | $30.85 |
| Indicator | ICUI | HSAI |
|---|---|---|
| Relative Strength Index (RSI) | 53.24 | 46.66 |
| Support Level | $130.63 | $20.00 |
| Resistance Level | $133.62 | $23.98 |
| Average True Range (ATR) | 4.31 | 1.02 |
| MACD | 1.31 | 0.40 |
| Stochastic Oscillator | 99.24 | 56.02 |
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.